These roundtables will explore how advances in computational neuroscience, molecular biology, and genomics are transforming understandings of disease, shifting perceptions of illness toward more mechanistic, data-driven, and personalized frameworks, and enabling earlier detection, refined diagnosis, and targeted therapies.